Skip to main content
Top
Published in: BMC Cancer 1/2014

Open Access 01-12-2014 | Research article

Men’s knowledge and attitudes towards dietary prevention of a prostate cancer diagnosis: a qualitative study

Authors: Jeremy P Horwood, Kerry NL Avery, Chris Metcalfe, Jenny L Donovan, Freddie C Hamdy, David E Neal, J Athene Lane

Published in: BMC Cancer | Issue 1/2014

Login to get access

Abstract

Background

Prostate cancer (PC) incidence and progression may be influenced by dietary factors, but little is known about the acceptability of dietary modification to men at increased risk of PC. Qualitative interviews with men participating in the ProDiet study were undertaken to explore the feasibility of implementing dietary interventions for the prevention of prostate cancer.

Methods

An interview study nested within the ProDiet randomised feasibility trial of dietary interventions to prevent a PC diagnosis. Men (n = 133) who previously participated in community based prostate specific antigen (PSA) testing without PC but who were at increased risk of the disease were randomly allocation to both lycopene (lycopene or placebo capsules or lycopene rich diet) and green tea (green tea or placebo capsules or green tea drink) for 6 months. Semi-structured interviews were conducted with participants shortly after randomisation, to investigate attitudes towards dietary modification for PC prevention and dietary information. Interviews were audio-recorded, transcribed and analysed to identify common themes.

Results

Interviews were conducted with 21 participants aged 52-72 years with PSA levels between 2.5 and 2.95 ng/ml, or a negative prostate biopsy result. Most men identified the major causes of cancer in general to include diet, environment, ageing and genetic factors. This contrasted sharply with men’s uncertainty about PC aetiology, and the function of the prostate. Men were confused by conflicting messages in the media about dietary practices to promote health overall, but were positive about the potential of lycopene and green tea in relation to PC prevention, valuing their natural components. Furthermore these men wanted tailored dietary advice for PC prevention from their clinicians, whom they considered a trusted source of information.

Conclusion

Men at elevated risk of PC reported uncertainty about PC aetiology and the role of diet in PC prevention, but enthusiasm for dietary modifications that were perceived as ‘simple’ and ‘natural’. The men looked to clinicians to provide consistent disease specific dietary advice. These factors should be taken into consideration by clinicians discussing elevated PSA results with patients and those planning to embark on future trials investigating dietary modification interventions for the prevention of a PC diagnosis.
Literature
1.
go back to reference World Cancer Research Fund AIfCR: Food, Nutrition, Physical Acitivity, and the Prevention of Cancer: a Global Perspective. 2007, Washington, DC: AICR World Cancer Research Fund AIfCR: Food, Nutrition, Physical Acitivity, and the Prevention of Cancer: a Global Perspective. 2007, Washington, DC: AICR
2.
go back to reference Hori S, Butler E, McLoughlin J: Prostate cancer and diet: food for thought?. BJU Int. 2011, 107 (9): 1348-1359. 10.1111/j.1464-410X.2010.09897.x.CrossRefPubMed Hori S, Butler E, McLoughlin J: Prostate cancer and diet: food for thought?. BJU Int. 2011, 107 (9): 1348-1359. 10.1111/j.1464-410X.2010.09897.x.CrossRefPubMed
3.
go back to reference Sonn GA, Aronson W, Litwin MS: Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis. 2005, 8 (4): 304-310. 10.1038/sj.pcan.4500825.CrossRefPubMed Sonn GA, Aronson W, Litwin MS: Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis. 2005, 8 (4): 304-310. 10.1038/sj.pcan.4500825.CrossRefPubMed
4.
go back to reference Ma RW, Chapman K: A systematic review of the effect of diet in prostate cancer prevention and treatment. J Hum Nutr Diet. 2009, 22 (3): 187-199. 10.1111/j.1365-277X.2009.00946.x.CrossRefPubMed Ma RW, Chapman K: A systematic review of the effect of diet in prostate cancer prevention and treatment. J Hum Nutr Diet. 2009, 22 (3): 187-199. 10.1111/j.1365-277X.2009.00946.x.CrossRefPubMed
5.
go back to reference Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, et al: Effect of selenium and vitamin e on risk of prostate cancer and other cancers: the selenium and vitamin e cancer prevention trial (select). JAMA. 2009, 301 (1): 39-51. 10.1001/jama.2008.864.CrossRefPubMed Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, et al: Effect of selenium and vitamin e on risk of prostate cancer and other cancers: the selenium and vitamin e cancer prevention trial (select). JAMA. 2009, 301 (1): 39-51. 10.1001/jama.2008.864.CrossRefPubMed
6.
go back to reference Van Patten CL, De Boer JG, Tomlinson Guns ES: Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. J Urol. 2008, 180 (6): 2314-2321. 10.1016/j.juro.2008.08.078.CrossRefPubMed Van Patten CL, De Boer JG, Tomlinson Guns ES: Diet and dietary supplement intervention trials for the prevention of prostate cancer recurrence: a review of the randomized controlled trial evidence. J Urol. 2008, 180 (6): 2314-2321. 10.1016/j.juro.2008.08.078.CrossRefPubMed
7.
go back to reference Syed DN, Khan N, Afaq F, Mukhtar H: Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev. 2007, 16 (11): 2193-2203. 10.1158/1055-9965.EPI-06-0942.CrossRefPubMed Syed DN, Khan N, Afaq F, Mukhtar H: Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev. 2007, 16 (11): 2193-2203. 10.1158/1055-9965.EPI-06-0942.CrossRefPubMed
8.
go back to reference Henning SM, Wang P, Said J, Magyar C, Castor B, Doan N, Tosity C, Moro A, Gao K, Li L, Heber D: Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis. J Nutr Biochem. 2012, 23 (11): 1537-1542. 10.1016/j.jnutbio.2011.10.007.CrossRefPubMedPubMedCentral Henning SM, Wang P, Said J, Magyar C, Castor B, Doan N, Tosity C, Moro A, Gao K, Li L, Heber D: Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis. J Nutr Biochem. 2012, 23 (11): 1537-1542. 10.1016/j.jnutbio.2011.10.007.CrossRefPubMedPubMedCentral
9.
go back to reference Khan N, Adhami VM, Mukhtar H: Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr Cancer. 2009, 61 (6): 836-841. 10.1080/01635580903285056.CrossRefPubMedPubMedCentral Khan N, Adhami VM, Mukhtar H: Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies. Nutr Cancer. 2009, 61 (6): 836-841. 10.1080/01635580903285056.CrossRefPubMedPubMedCentral
10.
go back to reference Lin YW, Hu ZH, Wang X, Mao QQ, Qin J, Zheng XY, Xie LP: Tea consumption and prostate cancer: an updated meta-analysis. World J Surg Oncol. 2014, 12: 38-10.1186/1477-7819-12-38.CrossRefPubMedPubMedCentral Lin YW, Hu ZH, Wang X, Mao QQ, Qin J, Zheng XY, Xie LP: Tea consumption and prostate cancer: an updated meta-analysis. World J Surg Oncol. 2014, 12: 38-10.1186/1477-7819-12-38.CrossRefPubMedPubMedCentral
11.
go back to reference Avery KNL, Donovan JL, Gilbert E, Davis M, Emmett P, Down L, Oliver S, Neal DE, Hamdy FC, Lane JA: Men with prostate cancer make positive dietary changes following diagnosis and treatment. Cancer Causes Control. 2013, 24 (6): 1119-1128. 10.1007/s10552-013-0189-x.CrossRefPubMed Avery KNL, Donovan JL, Gilbert E, Davis M, Emmett P, Down L, Oliver S, Neal DE, Hamdy FC, Lane JA: Men with prostate cancer make positive dietary changes following diagnosis and treatment. Cancer Causes Control. 2013, 24 (6): 1119-1128. 10.1007/s10552-013-0189-x.CrossRefPubMed
12.
go back to reference Kronenwetter C, Weidner G, Pettengill E, Marlin R, Crutchfield L, McCormac P, Raisin CJ, Ornish D: A qualitative analysis of interviews of men with early stage prostate cancer: the Prostate Cancer Lifestyle Trial. Cancer Nurs. 2005, 28 (2): 99-107.CrossRefPubMed Kronenwetter C, Weidner G, Pettengill E, Marlin R, Crutchfield L, McCormac P, Raisin CJ, Ornish D: A qualitative analysis of interviews of men with early stage prostate cancer: the Prostate Cancer Lifestyle Trial. Cancer Nurs. 2005, 28 (2): 99-107.CrossRefPubMed
13.
go back to reference Davison BJ, Breckon E: Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Couns. 2012, 87 (3): 369-374. 10.1016/j.pec.2011.11.009.CrossRefPubMed Davison BJ, Breckon E: Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Couns. 2012, 87 (3): 369-374. 10.1016/j.pec.2011.11.009.CrossRefPubMed
14.
go back to reference de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais da Silva F, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schröder FH, European Randomized Screening for Prostate Cancer (ERSPC) Trial; International Prostate Cancer Screening Trials Evaluation Group: Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer. 2002, 97 (2): 237-244. 10.1002/ijc.1588.CrossRefPubMed de Koning HJ, Auvinen A, Berenguer Sanchez A, Calais da Silva F, Ciatto S, Denis L, Gohagan JK, Hakama M, Hugosson J, Kranse R, Nelen V, Prorok PC, Schröder FH, European Randomized Screening for Prostate Cancer (ERSPC) Trial; International Prostate Cancer Screening Trials Evaluation Group: Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial. Int J Cancer. 2002, 97 (2): 237-244. 10.1002/ijc.1588.CrossRefPubMed
15.
go back to reference Gohagan JK, Prorok PC, Hayes RB, Kramer BS: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials. 2000, 21 (6 Suppl): 251S-272S.CrossRefPubMed Gohagan JK, Prorok PC, Hayes RB, Kramer BS: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials. 2000, 21 (6 Suppl): 251S-272S.CrossRefPubMed
16.
go back to reference Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, Dahm P: Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ. 2010, 341: c4543-10.1136/bmj.c4543.CrossRefPubMedPubMedCentral Djulbegovic M, Beyth RJ, Neuberger MM, Stoffs TL, Vieweg J, Djulbegovic B, Dahm P: Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ. 2010, 341: c4543-10.1136/bmj.c4543.CrossRefPubMedPubMedCentral
17.
go back to reference Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, Bray F: International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012, 61 (6): 1079-1092. 10.1016/j.eururo.2012.02.054.CrossRefPubMed Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, Bray F: International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012, 61 (6): 1079-1092. 10.1016/j.eururo.2012.02.054.CrossRefPubMed
18.
go back to reference Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA: The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003, 349 (3): 215-224. 10.1056/NEJMoa030660.CrossRefPubMed Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA: The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003, 349 (3): 215-224. 10.1056/NEJMoa030660.CrossRefPubMed
19.
go back to reference Lane JA, Hamdy FC, Martin RM, Turner EL, Neal DE, Donovan JL: Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies. Eur J Cancer. 2010, 46 (17): 3095-3101. 10.1016/j.ejca.2010.09.016.CrossRefPubMed Lane JA, Hamdy FC, Martin RM, Turner EL, Neal DE, Donovan JL: Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies. Eur J Cancer. 2010, 46 (17): 3095-3101. 10.1016/j.ejca.2010.09.016.CrossRefPubMed
20.
go back to reference Ajzen I: The theory of planned behaviour. Organ Behav Hum Decis Process. 1991, 50 (2): 179-211. 10.1016/0749-5978(91)90020-T.CrossRef Ajzen I: The theory of planned behaviour. Organ Behav Hum Decis Process. 1991, 50 (2): 179-211. 10.1016/0749-5978(91)90020-T.CrossRef
21.
go back to reference Sandelowski M: Sample-size in qualitative research. Res Nurs Health. 1995, 18 (2): 179-183. 10.1002/nur.4770180211.CrossRefPubMed Sandelowski M: Sample-size in qualitative research. Res Nurs Health. 1995, 18 (2): 179-183. 10.1002/nur.4770180211.CrossRefPubMed
22.
go back to reference Braun VCV: Using thematic analysis in psychology. Qual Res Psychol. 2006, 3: 77-101. 10.1191/1478088706qp063oa.CrossRef Braun VCV: Using thematic analysis in psychology. Qual Res Psychol. 2006, 3: 77-101. 10.1191/1478088706qp063oa.CrossRef
23.
go back to reference Glaser BS, Strauss AL: The Discovery of Grounded Theory. Strategies for Qualitative Research. 1967, Chicago: Aldine Glaser BS, Strauss AL: The Discovery of Grounded Theory. Strategies for Qualitative Research. 1967, Chicago: Aldine
24.
go back to reference Rose D, O’Reilly K: The ESRC review of Government Social Classifications. 1998, London: Economic and Social Research Council and the Government Statistical Service Rose D, O’Reilly K: The ESRC review of Government Social Classifications. 1998, London: Economic and Social Research Council and the Government Statistical Service
25.
go back to reference Casey R, Rea D, McDermott T, Grainger R, Butler M, Thornhill J: Prostate cancer knowledge in Irish men. J Cancer Educ. 2012, 27 (1): 120-131. 10.1007/s13187-011-0256-5.CrossRefPubMed Casey R, Rea D, McDermott T, Grainger R, Butler M, Thornhill J: Prostate cancer knowledge in Irish men. J Cancer Educ. 2012, 27 (1): 120-131. 10.1007/s13187-011-0256-5.CrossRefPubMed
26.
go back to reference Fitzpatrick JM, Kirby RS, Brough CL, Saggerson AL: Awareness of prostate cancer among patients and the general public: results of an international survey. Prostate Cancer Prostatic Dis. 2009, 12 (4): 347-354. 10.1038/pcan.2009.30.CrossRefPubMedPubMedCentral Fitzpatrick JM, Kirby RS, Brough CL, Saggerson AL: Awareness of prostate cancer among patients and the general public: results of an international survey. Prostate Cancer Prostatic Dis. 2009, 12 (4): 347-354. 10.1038/pcan.2009.30.CrossRefPubMedPubMedCentral
27.
go back to reference Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E: Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer. 2000, 88 (3): 674-684. 10.1002/(SICI)1097-0142(20000201)88:3<674::AID-CNCR26>3.0.CO;2-R.CrossRefPubMed Demark-Wahnefried W, Peterson B, McBride C, Lipkus I, Clipp E: Current health behaviors and readiness to pursue life-style changes among men and women diagnosed with early stage prostate and breast carcinomas. Cancer. 2000, 88 (3): 674-684. 10.1002/(SICI)1097-0142(20000201)88:3<674::AID-CNCR26>3.0.CO;2-R.CrossRefPubMed
28.
go back to reference Mróz LW, Chapman GE, Oliffe JL, Bottorff JL: Men, food, and prostate cancer: gender influences on men’s diets. Am J Mens Health. 2011, 5 (2): 177-187. 10.1177/1557988310379152.CrossRefPubMed Mróz LW, Chapman GE, Oliffe JL, Bottorff JL: Men, food, and prostate cancer: gender influences on men’s diets. Am J Mens Health. 2011, 5 (2): 177-187. 10.1177/1557988310379152.CrossRefPubMed
29.
go back to reference Courtenay WH: Constructions of masculinity and their influence on men’s well-being: a theory of gender and health. Soc Sci Med. 2000, 50 (10): 1385-1401. 10.1016/S0277-9536(99)00390-1.CrossRefPubMed Courtenay WH: Constructions of masculinity and their influence on men’s well-being: a theory of gender and health. Soc Sci Med. 2000, 50 (10): 1385-1401. 10.1016/S0277-9536(99)00390-1.CrossRefPubMed
30.
go back to reference Gough B, Conner MT: Barriers to healthy eating amongst men: a qualitative analysis. Soc Sci Med. 2006, 62 (2): 387-395. 10.1016/j.socscimed.2005.05.032.CrossRefPubMed Gough B, Conner MT: Barriers to healthy eating amongst men: a qualitative analysis. Soc Sci Med. 2006, 62 (2): 387-395. 10.1016/j.socscimed.2005.05.032.CrossRefPubMed
31.
go back to reference Ponholzer A, Struhal G, Madersbacher S: Frequent use of complementary medicine by prostate cancer patients. Eur Urol. 2003, 43 (6): 604-608. 10.1016/S0302-2838(03)00155-6.CrossRefPubMed Ponholzer A, Struhal G, Madersbacher S: Frequent use of complementary medicine by prostate cancer patients. Eur Urol. 2003, 43 (6): 604-608. 10.1016/S0302-2838(03)00155-6.CrossRefPubMed
32.
go back to reference Jensen KOD, Holm L: Preferences, quantities and concerns: socio-cultural perspectives on the gendered consumption of foods. Eur J Clin Nutr. 1999, 53: 351-359. 10.1038/sj.ejcn.1600767.CrossRef Jensen KOD, Holm L: Preferences, quantities and concerns: socio-cultural perspectives on the gendered consumption of foods. Eur J Clin Nutr. 1999, 53: 351-359. 10.1038/sj.ejcn.1600767.CrossRef
33.
go back to reference Banks I: Haynes Owner’s Workshop Manuals. 2002, London: Haynes Banks I: Haynes Owner’s Workshop Manuals. 2002, London: Haynes
34.
go back to reference Cuthbertson I, Callaghan G: Men Inside Out. 2003, Sydney: Macmillan Publishers Cuthbertson I, Callaghan G: Men Inside Out. 2003, Sydney: Macmillan Publishers
35.
go back to reference Robertson S: Understanding Men and Health: Masculinities, Identity, and Well-Being. 2007, Maidenhead: Open University Press Robertson S: Understanding Men and Health: Masculinities, Identity, and Well-Being. 2007, Maidenhead: Open University Press
Metadata
Title
Men’s knowledge and attitudes towards dietary prevention of a prostate cancer diagnosis: a qualitative study
Authors
Jeremy P Horwood
Kerry NL Avery
Chris Metcalfe
Jenny L Donovan
Freddie C Hamdy
David E Neal
J Athene Lane
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2014
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-14-812

Other articles of this Issue 1/2014

BMC Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine